109 related articles for article (PubMed ID: 22818209)
61. FDG-PET performed concurrently with initial I-131 ablation for differentiated thyroid cancer.
Iwano S; Kato K; Ito S; Tsuchiya K; Naganawa S
Ann Nucl Med; 2012 Apr; 26(3):207-13. PubMed ID: 22160654
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative I131 whole-body scan and elevated thyroglobulin levels.
Caobelli F; Pizzocaro C; Guerra UP
Clin Nucl Med; 2013 Mar; 38(3):196. PubMed ID: 23357825
[No Abstract] [Full Text] [Related]
63. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative I131 whole- body scan and elevated thyroglobulin levels.
Marcus CS
Clin Nucl Med; 2013 Mar; 38(3):195. PubMed ID: 23354036
[No Abstract] [Full Text] [Related]
64. Detectable thyroglobulin with negative imaging in differentiated thyroid cancer patients. What to do with negative anatomical imaging and radioiodine scan?
Giovanella L; Treglia G; Ceriani L; Verburg F
Nuklearmedizin; 2014; 53(1):1-10. PubMed ID: 24305950
[TBL] [Abstract][Full Text] [Related]
65. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
66. [Importance of PET for surgery of recurrent thyroid cancer].
Haane C; Colombo-Benkmann M
Chirurg; 2014 Jun; 85(6):481-6. PubMed ID: 24840933
[TBL] [Abstract][Full Text] [Related]
67. Positron emission tomography in non-medullary thyroid cancer.
Ho Shon I; Depcynzski B; Lin M; Clark JR; Wong V; Lin P; Campbell P
ANZ J Surg; 2011 Mar; 81(3):116-24. PubMed ID: 21342381
[TBL] [Abstract][Full Text] [Related]
68. Radioguided surgery of thyroid carcinoma recurrences: the role of preoperative (99m)Tc-labeled human serum albumin macroaggregates-SPECT/CT mapping.
Giovanella L; Suriano S; Lunghi L; Bongiovanni M; Ceriani L
Clin Nucl Med; 2013 Apr; 38(4):e207-9. PubMed ID: 23455530
[TBL] [Abstract][Full Text] [Related]
69. Positron emission tomography/computed tomography in patients treated for differentiated thyroid carcinomas.
Giovanella L
Expert Rev Endocrinol Metab; 2012 Jan; 7(1):35-43. PubMed ID: 30736109
[TBL] [Abstract][Full Text] [Related]
70. Diagnostic value of computed tomography combined with ultrasonography in detecting cervical recurrence in patients with thyroid cancer.
Hong EK; Kim JH; Lee J; Yoo RE; Kim SC; Kim MJ; Park YJ; Chung EJ; Ryu YJ; Lee E; Kang KM; Yun TJ; Choi SH; Sohn CH
Head Neck; 2019 May; 41(5):1206-1212. PubMed ID: 30552732
[TBL] [Abstract][Full Text] [Related]
71. Persistent/Recurrent Differentiated Thyroid Cancer: Clinical and Radiological Characteristics of Persistent Disease and Clinical Recurrence Based on Computed Tomography Analysis.
Kim TM; Kim JH; Yoo RE; Kim SC; Chung EJ; Hong EK; Jo S; Kang KM; Choi SH; Sohn CH; Rhim JH; Park SW; Park YJ
Thyroid; 2018 Nov; 28(11):1490-1499. PubMed ID: 30226443
[TBL] [Abstract][Full Text] [Related]
72. Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.
Xue YL; Qiu ZL; Song HJ; Luo QY
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):768-78. PubMed ID: 23242250
[TBL] [Abstract][Full Text] [Related]
73. Hybrid Molecular Imaging in Differentiated Thyroid Carcinoma.
Schmidt D; Kuwert T
Front Horm Res; 2016; 45():37-45. PubMed ID: 27003310
[TBL] [Abstract][Full Text] [Related]
74. Positron emission tomography-computed tomography coregistration for diagnosis and intraoperative localization in recurrent nelson syndrome.
Hintz EB; Tomlin JM; Chengazi V; Vates GE
J Neurol Surg Rep; 2013 Jun; 74(1):33-6. PubMed ID: 23943718
[TBL] [Abstract][Full Text] [Related]
75. Suture Granuloma and Surgical Clips as a Mimic of Thyroid Cancer Recurrence.
Frye CC; Smith E; Du X; Itani M; Brown T; Jasim S
AACE Clin Case Rep; 2022; 8(4):185-187. PubMed ID: 35959081
[No Abstract] [Full Text] [Related]
76. Discussion.
Surgery; 2018 Oct; 164(4):877-878. PubMed ID: 30244917
[No Abstract] [Full Text] [Related]
77. Improving
Le Goas M; Paquet M; Paquirissamy A; Guglielmi J; Compin C; Thariat J; Vassaux G; Geertsen V; Humbert O; Renault JP; Carrot G; Pourcher T; Cambien B
Int J Nanomedicine; 2019; 14():7933-7946. PubMed ID: 31686819
[TBL] [Abstract][Full Text] [Related]
78. Predicting
Liu M; Cheng L; Jin Y; Ruan M; Sheng S; Chen L
Sci Rep; 2018 Mar; 8(1):4352. PubMed ID: 29531251
[TBL] [Abstract][Full Text] [Related]
79. Association between Volumetric Analysis of Lung Metastases on F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography and Short-term Progression after I-131 Therapy for Differentiated Thyroid Carcinoma.
Maruoka Y; Baba S; Isoda T; Kitamura Y; Abe K; Sasaki M; Honda H
Indian J Nucl Med; 2017; 32(3):167-172. PubMed ID: 28680197
[TBL] [Abstract][Full Text] [Related]
80. Positron emission tomography-computed tomography evaluation for recurrent differentiated thyroid carcinoma.
Makeieff M; Burcia V; Raingeard I; Eberlé MC; Cartier C; Garrel R; Crampette L; Guerrier B
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Oct; 129(5):251-6. PubMed ID: 22818209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
